November 10th 2022
The tool successfully identified children with high asthma risk as young as 3 years of age. The screening tool was found to be more accurate at predicting asthma, persistent wheezing, and related emergency room visits and hospitalizations than standard screening and diagnostic tools.
Satellite Symposia at the Annual Radiation Oncology Meeting
September 28-29, 2024
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process
View More
Improving Outcomes Across Frontline and R/R SCLC Care in Community Treatment Settings
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Cost Effectiveness Analysis of Biomarkers for Guiding Asthma Treatment in Children
August 2nd 2022Using biomarkers for tailoring asthma treatment can reduce the frequency of asthma exacerbations. Some recent results suggest that eosinophil-guided asthma management is associated with lower annual costs than FeNO-guided management.
Read More
American Academy of Family Physicians Awarded $31 Million for Comparative Asthma Treatment Study
August 1st 2022The Patient-Centered Outcomes Research Institute (PCORI) has approved an award for the American Academy of Family Physicians (AAFP) of $31 million to fund a large comparative study of asthma treatments.
Read More
An Upstream Strategy for Treating Severe Asthma
June 17th 2022Thymic stromal lymphopoietin (TSLP) has been identified as starting the cascades of cytokines that result in the inflammation that underlies many cases of severe asthma. A review paper discusses how Tezspire inhibits TSLP and the evidence for its safety and efficacy in numerous clinical trials.
Read More
IL-13 in People with Allergic Asthma May Offer Some Protection Against Severe COVID
June 14th 2022University of North Carolina researchers report that interleukin-13, responsible for inflammation and severe asthma symptoms, may have properties that fend off the SARS-CoV-2 virus that causes COVID-19.
Read More
Real-world study conducted in Japan shows Dupixent (dupilumab) reduced the number of annual severe asthma exacerbations by 53%. There were some reports of adverse events associated with high eosinophil levels in patients who switched to Dupixent after taking a different biologic.
Read More
Tezspire Misses Primary End Point in SOURCE, but Provides Other Benefits for Patients With Asthma
April 22nd 2022Despite missing the primary end point of significantly reducing oral corticosteroid dose, patients with asthma on Tezspire in the SOURCE trial received other benefits from the drug.
Read More
5 Exacerbation-prone Phenotypes Were Discovered Among Asthma and COPD Patients
April 14th 2022Five phenotype clusters were discovered to be associated with the exacerbation, or worsening, of chronic inflammatory airway diseases of asthma and chronic obstructive pulmonary disease (COPD), according to a recent study published in PLOS ONE.
Read More
FDA Updates for Week of March 14, 2022
March 19th 2022FDA approves first generic of Symbicort for asthma and COPD and first therapy for rare seizure disorder, Rinvoq and Lynparza get nods for new indications, the agency approves a new delivery system for Alzheimer’s therapy, regulators extend review for Opzelura for skin condition and issue CRL for Fasenra for chronic rhinosinusitis.
Read More
Many Young Adults with Asthma Aren't Completely Prepped to Transition to Adult Asthma Care
November 23rd 2021Young adults with asthma were recently surveyed on their preparation of the transition to adult asthma care. Half of all those surveyed did not remember being introduced to concepts of transitioning care, including asthma self-management, by their pediatric asthma provider.
Read More